GC Biopharma Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
GC Biopharma has a total shareholder equity of ₩1,488.1B and total debt of ₩778.4B, which brings its debt-to-equity ratio to 52.3%. Its total assets and total liabilities are ₩2,729.5B and ₩1,241.4B respectively. GC Biopharma's EBIT is ₩26.4B making its interest coverage ratio 0.8. It has cash and short-term investments of ₩78.1B.
Belangrijke informatie
52.3%
Verhouding schuld/eigen vermogen
₩778.45b
Schuld
| Rente dekkingsratio | 0.8x |
| Contant | ₩78.10b |
| Aandelen | ₩1.49t |
| Totaal verplichtingen | ₩1.24t |
| Totaal activa | ₩2.73t |
Recente financiële gezondheidsupdates
Is GC Biopharma (KRX:006280) A Risky Investment?
Oct 17
Is GC Biopharma (KRX:006280) A Risky Investment?
May 25We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt
May 02Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet
Jan 31Recent updates
Is GC Biopharma (KRX:006280) A Risky Investment?
Oct 17There's No Escaping GC Biopharma Corp.'s (KRX:006280) Muted Revenues
Aug 02A Look At The Fair Value Of GC Biopharma Corp. (KRX:006280)
Jul 12Is GC Biopharma (KRX:006280) A Risky Investment?
May 25GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry
Mar 08We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt
May 02Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?
Mar 10Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%
Feb 18Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet
Jan 31Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)
Jan 14What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition
Dec 27
Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 09Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 21Analyse van de financiële positie
Kortlopende schulden: A006280's short term assets (₩1,168.2B) exceed its short term liabilities (₩754.1B).
Langlopende schulden: A006280's short term assets (₩1,168.2B) exceed its long term liabilities (₩487.3B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: A006280's net debt to equity ratio (47.1%) is considered high.
Schuld verminderen: A006280's debt to equity ratio has increased from 35.6% to 52.3% over the past 5 years.
Schuldendekking: A006280's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: A006280's interest payments on its debt are not well covered by EBIT (0.8x coverage).